The final stages of folding of the membrane protein bacteriorhodopsin occur by kinetically indistinguishable parallel folding paths that are mediated by pH.
The folding of the transmembrane protein bacteriorhodopsin that occurs during the binding of its retinal cofactor is investigated in a membrane-like environment. Changes in the retinal absorption band reveal two transient retinal-protein intermediate states, with apparent absorption maxima at 380 nm and 440 nm, respectively. Studies on a bacteriorhodopsin mutant of Lys216, which cannot bind retinal covalently, add to evidence that retinal is non-covalently bound in these intermediate states. The two retinal-protein intermediates are genuine intermediate states that form in parallel, each with an observed rate constant of 1.1 s-1. Meanwhile no formation of the folded state is detected. Folded bacteriorhodopsin, with all trans retinal covalently bound, forms from both retinal-bound intermediates with the same apparent rate constant of 0.0070 s-1 that is independent of retinal concentration. Retinal isomerisation then occurs with a rate constant of 0.00033 s-1 to give bacteriorhodopsin containing all trans and 13 cis-retinal. These results provide experimental evidence for multiple folding routes for a membrane protein that are pH dependent, with pH conditions determining the apparent folding route. These observed parallel folding paths are kinetically indistinguishable, which contrasts with most other observations of parallel folding pathways where only pathways with different kinetics have been reported. Furthermore, together with previous work, this study shows that bacteriorhodopsin has to populate at least two folding intermediates, during folding in the mixed lipid micelles investigated here, before the final fold is attained.
Lu
H
H
Department of Biochemistry, Imperial College of Science, Technology and Medicine, London, UK.
Booth
P J
PJ
D001436:Bacteriorhodopsins / Q000737:chemistry* / Q000378:metabolism*; D003624:Darkness; D006863:Hydrogen-Ion Concentration; D007536:Isomerism; D007700:Kinetics; D008027:Light; D008565:Membrane Proteins / Q000737:chemistry* / Q000378:metabolism*; D008567:Membranes, Artificial; D008823:Micelles; D010713:Phosphatidylcholines / Q000378:metabolism; D011487:Protein Conformation / Q000187:drug effects; D011489:Protein Denaturation / Q000187:drug effects; D017510:Protein Folding; D020673:Protein Renaturation; D011522:Protons; D012172:Retinaldehyde / Q000737:chemistry / Q000378:metabolism*; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D013053:Spectrophotometry; D013816:Thermodynamics
D008565:Membrane Proteins; D008567:Membranes, Artificial; D008823:Micelles; D010713:Phosphatidylcholines; D011522:Protons; D012967:Sodium Dodecyl Sulfate; D001436:Bacteriorhodopsins; D012172:Retinaldehyde